200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 26569-47-1
CAS No: 26569-47-1 Catalog No: AG002TQB MDL No:
Title | Journal |
---|---|
Antileishmanial bis-arylimidamides: DB766 analogs modified in the linker region and bis-arylimidamide structure-activity relationships. | Bioorganic & medicinal chemistry letters 20121115 |
Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies. | Protoplasma 20101001 |
Grand challenge: investigating the oxidant hypothesis in the realm of systems physiology and disease pathogenesis. | Frontiers in physiology 20100101 |
The diamidine DB75 targets the nucleus of Plasmodium falciparum. | Malaria journal 20090101 |
Molecular strategies to inhibit HIV-1 replication. | Retrovirology 20050101 |
Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution. | Cancer research 20021215 |
Distribution of furamidine analogues in tumor cells: influence of the number of positive charges. | Journal of medicinal chemistry 20020509 |
Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry. | Rapid communications in mass spectrometry : RCM 20020101 |
Novel dications with unfused aromatic systems: trithiophene and trifuran derivatives of furimidazoline. | Chembiochem : a European journal of chemical biology 20010803 |
Inhibition of the HIV-1 rev-RRE complex formation by unfused aromatic cations. | Bioorganic & medicinal chemistry 20010501 |
A heterocyclic inhibitor of the REV-RRE complex binds to RRE as a dimer. | Biochemistry 20010206 |
© 2019 Angene International Limited. All rights Reserved.